• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoyl derivatives
• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Introduction to 3-Bromo-4-fluorobenzaldehyde (CAS No. 77771-02-9)

3-Bromo-4-fluorobenzaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 77771-02-9, is a significant intermediate in the realm of organic synthesis and pharmaceutical chemistry. This compound, featuring both bromine and fluorine substituents on a benzaldehyde backbone, exhibits unique electronic and steric properties that make it a valuable building block for the development of novel molecules.

The structural motif of 3-bromo-4-fluorobenzaldehyde combines the reactivity of an aldehyde group with the electronic effects of halogen atoms. The presence of a bromine atom at the 3-position and a fluorine atom at the 4-position introduces both electrophilic and nucleophilic sites, facilitating diverse synthetic transformations. This dual functionality has been exploited in various cross-coupling reactions, such as Suzuki-Miyaura, Heck, and Buchwald-Hartwig couplings, enabling the construction of complex aromatic systems.

In recent years, 3-bromo-4-fluorobenzaldehyde has garnered attention in the design of bioactive molecules. Its structural features are particularly relevant in medicinal chemistry, where halogenated aromatic compounds often exhibit enhanced binding affinity and metabolic stability. The compound has been employed in the synthesis of kinase inhibitors, anticancer agents, and other therapeutic candidates. For instance, studies have demonstrated its utility in generating fluorinated benzene derivatives that interact with specific biological targets, showcasing its potential in drug discovery.

The fluorine atom in 3-bromo-4-fluorobenzaldehyde plays a crucial role in modulating the pharmacokinetic properties of derived compounds. Fluorine substitution is a well-established strategy in pharmaceutical development to improve lipophilicity, reduce metabolic clearance, and enhance binding interactions. The bromine moiety further contributes to the compound's reactivity, allowing for further functionalization through palladium-catalyzed reactions. This combination makes 3-bromo-4-fluorobenzaldehyde a versatile precursor for synthesizing structurally diverse libraries of compounds.

Advances in synthetic methodologies have expanded the applications of 3-bromo-4-fluorobenzaldehyde. Modern catalytic systems have enabled more efficient and selective transformations, reducing side reactions and improving yields. For example, recent research has highlighted the use of photoredox catalysis in conjunction with this compound to achieve novel functionalizations that were previously inaccessible. Such innovations underscore the evolving role of 3-bromo-4-fluorobenzaldehyde as a cornerstone in synthetic organic chemistry.

The compound's significance extends beyond academic research into industrial applications. Pharmaceutical companies have leveraged its properties to develop proprietary libraries for high-throughput screening (HTS). The ability to rapidly derivatize 3-bromo-4-fluorobenzaldehyde into structurally diverse analogs has accelerated the discovery process for new therapeutic agents. Additionally, its use in material science has been explored, particularly in the synthesis of organic semiconductors and liquid crystals, where halogenated aromatics contribute to desirable electronic properties.

In conclusion, 3-bromo-4-fluorobenzaldehyde (CAS No. 77771-02-9) represents a critical intermediate with broad utility across multiple scientific disciplines. Its unique structural features and reactivity have positioned it as a key component in pharmaceutical synthesis, material science, and advanced organic chemistry research. As methodologies continue to evolve, the potential applications of this compound are expected to expand further, reinforcing its importance in modern chemical innovation.

• 78239-66-4(3-Bromo-4-fluorobenzyl bromide)
• 133059-43-5(4-Bromo-3-fluorobenzaldehyde)
• 398456-82-1(3-Bromo-2,6-difluorobenzaldehyde)
• 149947-15-9(3-Bromo-2-fluorobenzaldehyde)
• 861928-26-9(4-Bromo-5-fluoro-2-methylbenzaldehyde)
• 1007-15-4(1-(3-bromo-4-fluorophenyl)ethan-1-one)
• 188813-02-7(3-Bromo-5-fluorobenzaldehyde)
• 891180-59-9(2-Bromo-3-fluorobenzaldehyde)
• 477535-40-3(3,5-Dibromo-2-fluorobenzaldehyde)
• 1257665-03-4(3-Bromo-2-fluoro-5-methylbenzaldehyde)